<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37353777</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Significant hypomethylation of <i>MMP9</i> gene promoter in patients with systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>1056</StartPage><EndPage>1065</EndPage><MedlinePgn>1056-1065</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231185618</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Scholars are exploring novel diagnostic and prognostic biomarkers with higher sensitivity and specificity for systemic lupus erythematosus (SLE). In this regard, DNA methylation alterations have aroused attention. The association between the dysfunction of <i>MMP9</i> and <i>TNFAIP3</i> genes and SLE has been previously demonstrated. Therefore, in this study, we investigated the methylation level of <i>MMP9</i> and <i>TNFAIP3</i> promoters in peripheral blood mononuclear cells (PBMCs) of SLE patients and healthy controls.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Eighty Iranian SLE patients and 77 healthy individuals were enrolled. The methylation quantification endonuclease-resistant DNA (MethyQESD) method was used to assess methylation levels of <i>MMP9</i> and <i>TNFAIP3</i> in extracted DNA of PBMCs. To quantify the diagnostic utility of the promoter methylation level of these genes, the receiver operating characteristic (ROC) curve was constructed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS"><i>MMP9</i> promoter was significantly hypomethylated in SLE patients compared with healthy people (<i>p</i> &lt; 0.001), while there was no significant difference in terms of <i>TNFAIP3</i> promoter methylation levels (<i>p</i> = 0.167). Also, this differential <i>MMP9</i> methylation was observed in patients with renal involvement and patients without renal involvement (42.07 &#xb1; 25.73 vs 56.74 &#xb1; 29.71, <i>p</i> = 0.007). ROC analyses indicated that the diagnostic power of the <i>MMP9</i> promoter methylation level for SLE was 0.839 [95% CI (0.781-0.911)]. Moreover, <i>MMP9</i> methylation level was negatively correlated with creatinine and anti-dsDNA concentration and positively correlated with C3 and C4 levels.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of this study highlight the application of <i>MMP9</i> methylation level in PBMCs of SLE patients as a diagnostic biomarker.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ehtesham</LastName><ForeName>Naeim</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Genetics and Advanced Medical Technology, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran.</Affiliation><Identifier Source="RINGGOLD">162996</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Meical Genetics, School of Medicine, Iranshahr University of Medical Sciences, Iranshahr, Iran.</Affiliation><Identifier Source="RINGGOLD">461251</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosallaei</LastName><ForeName>Meysam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Personalized Medicine and Genometabolomics Research Center, Hope Generation Foundation, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, Iran.</Affiliation><Identifier Source="RINGGOLD">162996</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaboli Mahdiabadi</LastName><ForeName>Morteza</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Student Research Committee, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenarangi</LastName><ForeName>Taiebe</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biostatics and Epidemiology, University of Social Welfare and Rehabilitation Science, Tehran, Iran.</Affiliation><Identifier Source="RINGGOLD">48533</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farhadi</LastName><ForeName>Arezoo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Genetics and Biotechnology, Faculty of Life Science, Varamin- Pishva Branch, Islamic Azad University, Varamin, Iran.</Affiliation><Identifier Source="RINGGOLD">201592</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heidari</LastName><ForeName>Mohammad Foad</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, School of Allied Health Medicine, AJA University of Medical Sciences, Tehran, Iran.</Affiliation><Identifier Source="RINGGOLD">162996</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soroush</LastName><ForeName>Mohsen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rheumatology Section, Department of Internal Medicine, AJA University of Medical Sciences, Tehran, Iran.</Affiliation><Identifier Source="RINGGOLD">162996</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasrollahzadeh Sabet</LastName><ForeName>Mehrdad</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3402-4628</Identifier><AffiliationInfo><Affiliation>School of Medicine, Aja University of Medical Sciences, Tehran, Iran.</Affiliation><Identifier Source="RINGGOLD">162996</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behroozi</LastName><ForeName>Javad</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8975-7699</Identifier><AffiliationInfo><Affiliation>Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, Iran.</Affiliation><Identifier Source="RINGGOLD">162996</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.24.35</RegistryNumber><NameOfSubstance UI="D020780">Matrix Metalloproteinase 9</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.35</RegistryNumber><NameOfSubstance UI="C579270">MMP9 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020780" MajorTopicYN="N">Matrix Metalloproteinase 9</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MMP9</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">TNFAIP3</Keyword><Keyword MajorTopicYN="N">methylation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>24</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37353777</ArticleId><ArticleId IdType="doi">10.1177/09612033231185618</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>